Basal cell carcinoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
== Overview == | == Overview == | ||
Skin biopsy is the diagnostic study of choice for basal cell carcinoma. | [[Skin biopsy]] is the [[diagnostic study of choice]] for basal cell carcinoma. | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Revision as of 18:34, 5 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma diagnostic study of choice |
|
Risk calculators and risk factors for Basal cell carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Skin biopsy is the diagnostic study of choice for basal cell carcinoma.
Diagnostic Study of Choice
Study of choice
- Basal cell carcinoma is usually diagnosed based on physical examination[1]
- Skin biopsy is the gold standard test for the diagnosis of basal cell carcinoma
- The algorithm below demonstrates a biopsy protocol for patients with a suspected lesion[2].
References
- ↑ Warszawik-Hendzel O, Olszewska M, Maj M, Rakowska A, Czuwara J, Rudnicka L (December 2015). "Non-invasive diagnostic techniques in the diagnosis of squamous cell carcinoma". J Dermatol Case Rep. 9 (4): 89–97. doi:10.3315/jdcr.2015.1221. PMC 4733351. PMID 26848316.
- ↑ http://www.aafp.org/afp/2004/1015/p1481.html